Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Virginia lawmaker continues to push for legislation ending forced ultrasounds before abortions

On Thursday, Jan. 17, the Virginia's State Senate’s Education and Health Committee voted not to send the bill to the full state Senate for a vote, according to a recent report by the Daily Press in Newport News, Virginia.

Thumbnail

Arizona’s Medicaid work requirements approved

Arizona is the latest state to have approval for a Medicaid work requirement program—joining seven other states with approved programs.

Thumbnail

CVS and Walmart come to agreement after drug pricing battle

CVS Health and Walmart have reached a new, multiyear deal to continue their pharmacy business relationship. CVS announced the agreement Jan. 18, three days after the companies stated they would no longer be in the same network for filling prescription drugs after a pricing dispute.

Noninvasive blood flow imaging device receives FDA clearance

The FDA recently gave 501(k) clearance to medical imaging device iCertainty which noninvasively shows blood flow without the need of injection, dyes or radiation.

Thumbnail

CMS introduces new models to lower drug prices in Part D, Medicare Advantage

CMS’ Center for Medicare and Medicaid Innovation (CMMI) has announced a new model that aims to lower prescription drug prices in Medicare Part D and introduced several updates to Medicare Advantage (MA) plans.

Thumbnail

CMS proposes 2020 payment notice

The Trump administration’s CMS has proposed a number of changes to the 2020 coverage year, including making changes to the individual health insurance exchange and qualified health plan provisions.

Thumbnail

Healthcare is the hottest stock sector

The healthcare sector remains a sweet spot for the stock market, ranked the most favored sector on the S&P 500 among Wall Street research firms, Reuters reported.

Thumbnail

Congress to look into drug prices

Rising drug prices have caught the attention of the Congressional Committee on Oversight and Reform, which announced it will open a “sweeping” drug price investigation.